Loading…
Volatile organic compounds in plasma for the diagnosis of esophageal adenocarcinoma: a pilot study
Background and Aims A noninvasive screening test that can detect esophageal adenocarcinoma (EAC) at an earlier stage could improve the prognosis associated with EAC. The role of plasma volatile organic compounds (VOCs) for the diagnosis of EAC has not been previously studied. Methods Plasma samples...
Saved in:
Published in: | Gastrointestinal endoscopy 2016-10, Vol.84 (4), p.597-603 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c408t-d9fb07e4fe14765bc00d8d38271f6fb8e4101ba8f6fbb9e46a4084a56e7b2ba3 |
---|---|
cites | cdi_FETCH-LOGICAL-c408t-d9fb07e4fe14765bc00d8d38271f6fb8e4101ba8f6fbb9e46a4084a56e7b2ba3 |
container_end_page | 603 |
container_issue | 4 |
container_start_page | 597 |
container_title | Gastrointestinal endoscopy |
container_volume | 84 |
creator | Bhatt, Amit, MD Parsi, Mansour A., MD, MPH Stevens, Tyler, MD Gabbard, Scott, MD Kumaravel, Arthi, MD Jang, Sunguk, MD Grove, David, PhD Lopez, Rocio, MS Murthy, Sudish, MD Vargo, John J., MD, MPH Dweik, Raed, MD |
description | Background and Aims A noninvasive screening test that can detect esophageal adenocarcinoma (EAC) at an earlier stage could improve the prognosis associated with EAC. The role of plasma volatile organic compounds (VOCs) for the diagnosis of EAC has not been previously studied. Methods Plasma samples were collected from subjects with EAC and GERD before endoscopy. Twenty-two preselected VOCs were analyzed with selected ion flow tube mass spectrometry. Results The headspaces from 39 plasma samples (20 EAC, 19 GERD) were analyzed. The levels of 9 VOCs (acetonitrile, acrylonitrile, carbon disulfide, isoprene, 1-heptene, 3-methylhexane, [E]-2-nonene, hydrogen sulfide, and triethylamine) were significantly altered in EAC patients compared with GERD patients. A multivariable logistic regression analysis was performed to build a model for the prediction of EAC. The model identified patients with EAC with an area under the curve of 0.83 (95% confidence interval, 0.67-0.98). Conclusions Plasma VOCs may be useful in diagnosing EAC. Larger studies are needed to confirm our pilot study observations. |
doi_str_mv | 10.1016/j.gie.2015.11.031 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1820598846</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0016510715031594</els_id><sourcerecordid>1820598846</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-d9fb07e4fe14765bc00d8d38271f6fb8e4101ba8f6fbb9e46a4084a56e7b2ba3</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS1ERYfCA7BBXrJJ8M2Pk4CEVFX8SZW6aMXWurFvph6cONgJ0rwNz9Inw9EUFixYWZbOd6T7HcZegchBgHx7yPeW8kJAnQPkooQnbAeiazLZNN1TthMplNUgmnP2PMaDEKItSnjGzgspKykb2DH9zTtcrCPuwx4nq7n24-zXyURuJz47jCPywQe-3BM3FveTjzZyPzz8oujne9wTOo6GJq8xaDv5Ed9x5LN1fuFxWc3xBTsb0EV6-fhesLtPH--uvmTXN5-_Xl1eZ7oS7ZKZbuhFQ9VAUDWy7rUQpjVlWzQwyKFvqUpH99hun76jSmLCKqwlNX3RY3nB3pxq5-B_rBQXNdqoyTmcyK9RQVuIumvbSqYonKI6-BgDDWoOdsRwVCDUplYdVFKrNrUKQCW1iXn9WL_2I5m_xB-XKfD-FKB0409LQUVtadJkbCC9KOPtf-s__ENrZ9Me6L7TkeLBr2FK8hSoWCihbrdtt2mhTnTdVeVvKcWgew</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1820598846</pqid></control><display><type>article</type><title>Volatile organic compounds in plasma for the diagnosis of esophageal adenocarcinoma: a pilot study</title><source>Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list)</source><creator>Bhatt, Amit, MD ; Parsi, Mansour A., MD, MPH ; Stevens, Tyler, MD ; Gabbard, Scott, MD ; Kumaravel, Arthi, MD ; Jang, Sunguk, MD ; Grove, David, PhD ; Lopez, Rocio, MS ; Murthy, Sudish, MD ; Vargo, John J., MD, MPH ; Dweik, Raed, MD</creator><creatorcontrib>Bhatt, Amit, MD ; Parsi, Mansour A., MD, MPH ; Stevens, Tyler, MD ; Gabbard, Scott, MD ; Kumaravel, Arthi, MD ; Jang, Sunguk, MD ; Grove, David, PhD ; Lopez, Rocio, MS ; Murthy, Sudish, MD ; Vargo, John J., MD, MPH ; Dweik, Raed, MD</creatorcontrib><description>Background and Aims A noninvasive screening test that can detect esophageal adenocarcinoma (EAC) at an earlier stage could improve the prognosis associated with EAC. The role of plasma volatile organic compounds (VOCs) for the diagnosis of EAC has not been previously studied. Methods Plasma samples were collected from subjects with EAC and GERD before endoscopy. Twenty-two preselected VOCs were analyzed with selected ion flow tube mass spectrometry. Results The headspaces from 39 plasma samples (20 EAC, 19 GERD) were analyzed. The levels of 9 VOCs (acetonitrile, acrylonitrile, carbon disulfide, isoprene, 1-heptene, 3-methylhexane, [E]-2-nonene, hydrogen sulfide, and triethylamine) were significantly altered in EAC patients compared with GERD patients. A multivariable logistic regression analysis was performed to build a model for the prediction of EAC. The model identified patients with EAC with an area under the curve of 0.83 (95% confidence interval, 0.67-0.98). Conclusions Plasma VOCs may be useful in diagnosing EAC. Larger studies are needed to confirm our pilot study observations.</description><identifier>ISSN: 0016-5107</identifier><identifier>EISSN: 1097-6779</identifier><identifier>DOI: 10.1016/j.gie.2015.11.031</identifier><identifier>PMID: 26646671</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acetonitriles - blood ; Acrylonitrile - blood ; Adenocarcinoma - blood ; Adenocarcinoma - diagnosis ; Adult ; Aged ; Area Under Curve ; Butadienes - blood ; Carbon Disulfide - blood ; Case-Control Studies ; Cross-Sectional Studies ; Endoscopy, Digestive System ; Esophageal Neoplasms - blood ; Esophageal Neoplasms - diagnosis ; Ethylamines - blood ; Female ; Gastroenterology and Hepatology ; Gastroesophageal Reflux - blood ; Gastroesophageal Reflux - diagnosis ; Hemiterpenes - blood ; Hexanes - blood ; Humans ; Hydrogen Sulfide - blood ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Pentanes - blood ; Pilot Projects ; Volatile Organic Compounds - blood</subject><ispartof>Gastrointestinal endoscopy, 2016-10, Vol.84 (4), p.597-603</ispartof><rights>American Society for Gastrointestinal Endoscopy</rights><rights>2016 American Society for Gastrointestinal Endoscopy</rights><rights>Copyright © 2016 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-d9fb07e4fe14765bc00d8d38271f6fb8e4101ba8f6fbb9e46a4084a56e7b2ba3</citedby><cites>FETCH-LOGICAL-c408t-d9fb07e4fe14765bc00d8d38271f6fb8e4101ba8f6fbb9e46a4084a56e7b2ba3</cites><orcidid>0000-0002-7012-0732</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26646671$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bhatt, Amit, MD</creatorcontrib><creatorcontrib>Parsi, Mansour A., MD, MPH</creatorcontrib><creatorcontrib>Stevens, Tyler, MD</creatorcontrib><creatorcontrib>Gabbard, Scott, MD</creatorcontrib><creatorcontrib>Kumaravel, Arthi, MD</creatorcontrib><creatorcontrib>Jang, Sunguk, MD</creatorcontrib><creatorcontrib>Grove, David, PhD</creatorcontrib><creatorcontrib>Lopez, Rocio, MS</creatorcontrib><creatorcontrib>Murthy, Sudish, MD</creatorcontrib><creatorcontrib>Vargo, John J., MD, MPH</creatorcontrib><creatorcontrib>Dweik, Raed, MD</creatorcontrib><title>Volatile organic compounds in plasma for the diagnosis of esophageal adenocarcinoma: a pilot study</title><title>Gastrointestinal endoscopy</title><addtitle>Gastrointest Endosc</addtitle><description>Background and Aims A noninvasive screening test that can detect esophageal adenocarcinoma (EAC) at an earlier stage could improve the prognosis associated with EAC. The role of plasma volatile organic compounds (VOCs) for the diagnosis of EAC has not been previously studied. Methods Plasma samples were collected from subjects with EAC and GERD before endoscopy. Twenty-two preselected VOCs were analyzed with selected ion flow tube mass spectrometry. Results The headspaces from 39 plasma samples (20 EAC, 19 GERD) were analyzed. The levels of 9 VOCs (acetonitrile, acrylonitrile, carbon disulfide, isoprene, 1-heptene, 3-methylhexane, [E]-2-nonene, hydrogen sulfide, and triethylamine) were significantly altered in EAC patients compared with GERD patients. A multivariable logistic regression analysis was performed to build a model for the prediction of EAC. The model identified patients with EAC with an area under the curve of 0.83 (95% confidence interval, 0.67-0.98). Conclusions Plasma VOCs may be useful in diagnosing EAC. Larger studies are needed to confirm our pilot study observations.</description><subject>Acetonitriles - blood</subject><subject>Acrylonitrile - blood</subject><subject>Adenocarcinoma - blood</subject><subject>Adenocarcinoma - diagnosis</subject><subject>Adult</subject><subject>Aged</subject><subject>Area Under Curve</subject><subject>Butadienes - blood</subject><subject>Carbon Disulfide - blood</subject><subject>Case-Control Studies</subject><subject>Cross-Sectional Studies</subject><subject>Endoscopy, Digestive System</subject><subject>Esophageal Neoplasms - blood</subject><subject>Esophageal Neoplasms - diagnosis</subject><subject>Ethylamines - blood</subject><subject>Female</subject><subject>Gastroenterology and Hepatology</subject><subject>Gastroesophageal Reflux - blood</subject><subject>Gastroesophageal Reflux - diagnosis</subject><subject>Hemiterpenes - blood</subject><subject>Hexanes - blood</subject><subject>Humans</subject><subject>Hydrogen Sulfide - blood</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Pentanes - blood</subject><subject>Pilot Projects</subject><subject>Volatile Organic Compounds - blood</subject><issn>0016-5107</issn><issn>1097-6779</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAUhS1ERYfCA7BBXrJJ8M2Pk4CEVFX8SZW6aMXWurFvph6cONgJ0rwNz9Inw9EUFixYWZbOd6T7HcZegchBgHx7yPeW8kJAnQPkooQnbAeiazLZNN1TthMplNUgmnP2PMaDEKItSnjGzgspKykb2DH9zTtcrCPuwx4nq7n24-zXyURuJz47jCPywQe-3BM3FveTjzZyPzz8oujne9wTOo6GJq8xaDv5Ed9x5LN1fuFxWc3xBTsb0EV6-fhesLtPH--uvmTXN5-_Xl1eZ7oS7ZKZbuhFQ9VAUDWy7rUQpjVlWzQwyKFvqUpH99hun76jSmLCKqwlNX3RY3nB3pxq5-B_rBQXNdqoyTmcyK9RQVuIumvbSqYonKI6-BgDDWoOdsRwVCDUplYdVFKrNrUKQCW1iXn9WL_2I5m_xB-XKfD-FKB0409LQUVtadJkbCC9KOPtf-s__ENrZ9Me6L7TkeLBr2FK8hSoWCihbrdtt2mhTnTdVeVvKcWgew</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Bhatt, Amit, MD</creator><creator>Parsi, Mansour A., MD, MPH</creator><creator>Stevens, Tyler, MD</creator><creator>Gabbard, Scott, MD</creator><creator>Kumaravel, Arthi, MD</creator><creator>Jang, Sunguk, MD</creator><creator>Grove, David, PhD</creator><creator>Lopez, Rocio, MS</creator><creator>Murthy, Sudish, MD</creator><creator>Vargo, John J., MD, MPH</creator><creator>Dweik, Raed, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7012-0732</orcidid></search><sort><creationdate>20161001</creationdate><title>Volatile organic compounds in plasma for the diagnosis of esophageal adenocarcinoma: a pilot study</title><author>Bhatt, Amit, MD ; Parsi, Mansour A., MD, MPH ; Stevens, Tyler, MD ; Gabbard, Scott, MD ; Kumaravel, Arthi, MD ; Jang, Sunguk, MD ; Grove, David, PhD ; Lopez, Rocio, MS ; Murthy, Sudish, MD ; Vargo, John J., MD, MPH ; Dweik, Raed, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-d9fb07e4fe14765bc00d8d38271f6fb8e4101ba8f6fbb9e46a4084a56e7b2ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acetonitriles - blood</topic><topic>Acrylonitrile - blood</topic><topic>Adenocarcinoma - blood</topic><topic>Adenocarcinoma - diagnosis</topic><topic>Adult</topic><topic>Aged</topic><topic>Area Under Curve</topic><topic>Butadienes - blood</topic><topic>Carbon Disulfide - blood</topic><topic>Case-Control Studies</topic><topic>Cross-Sectional Studies</topic><topic>Endoscopy, Digestive System</topic><topic>Esophageal Neoplasms - blood</topic><topic>Esophageal Neoplasms - diagnosis</topic><topic>Ethylamines - blood</topic><topic>Female</topic><topic>Gastroenterology and Hepatology</topic><topic>Gastroesophageal Reflux - blood</topic><topic>Gastroesophageal Reflux - diagnosis</topic><topic>Hemiterpenes - blood</topic><topic>Hexanes - blood</topic><topic>Humans</topic><topic>Hydrogen Sulfide - blood</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Pentanes - blood</topic><topic>Pilot Projects</topic><topic>Volatile Organic Compounds - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhatt, Amit, MD</creatorcontrib><creatorcontrib>Parsi, Mansour A., MD, MPH</creatorcontrib><creatorcontrib>Stevens, Tyler, MD</creatorcontrib><creatorcontrib>Gabbard, Scott, MD</creatorcontrib><creatorcontrib>Kumaravel, Arthi, MD</creatorcontrib><creatorcontrib>Jang, Sunguk, MD</creatorcontrib><creatorcontrib>Grove, David, PhD</creatorcontrib><creatorcontrib>Lopez, Rocio, MS</creatorcontrib><creatorcontrib>Murthy, Sudish, MD</creatorcontrib><creatorcontrib>Vargo, John J., MD, MPH</creatorcontrib><creatorcontrib>Dweik, Raed, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gastrointestinal endoscopy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhatt, Amit, MD</au><au>Parsi, Mansour A., MD, MPH</au><au>Stevens, Tyler, MD</au><au>Gabbard, Scott, MD</au><au>Kumaravel, Arthi, MD</au><au>Jang, Sunguk, MD</au><au>Grove, David, PhD</au><au>Lopez, Rocio, MS</au><au>Murthy, Sudish, MD</au><au>Vargo, John J., MD, MPH</au><au>Dweik, Raed, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Volatile organic compounds in plasma for the diagnosis of esophageal adenocarcinoma: a pilot study</atitle><jtitle>Gastrointestinal endoscopy</jtitle><addtitle>Gastrointest Endosc</addtitle><date>2016-10-01</date><risdate>2016</risdate><volume>84</volume><issue>4</issue><spage>597</spage><epage>603</epage><pages>597-603</pages><issn>0016-5107</issn><eissn>1097-6779</eissn><abstract>Background and Aims A noninvasive screening test that can detect esophageal adenocarcinoma (EAC) at an earlier stage could improve the prognosis associated with EAC. The role of plasma volatile organic compounds (VOCs) for the diagnosis of EAC has not been previously studied. Methods Plasma samples were collected from subjects with EAC and GERD before endoscopy. Twenty-two preselected VOCs were analyzed with selected ion flow tube mass spectrometry. Results The headspaces from 39 plasma samples (20 EAC, 19 GERD) were analyzed. The levels of 9 VOCs (acetonitrile, acrylonitrile, carbon disulfide, isoprene, 1-heptene, 3-methylhexane, [E]-2-nonene, hydrogen sulfide, and triethylamine) were significantly altered in EAC patients compared with GERD patients. A multivariable logistic regression analysis was performed to build a model for the prediction of EAC. The model identified patients with EAC with an area under the curve of 0.83 (95% confidence interval, 0.67-0.98). Conclusions Plasma VOCs may be useful in diagnosing EAC. Larger studies are needed to confirm our pilot study observations.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26646671</pmid><doi>10.1016/j.gie.2015.11.031</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-7012-0732</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0016-5107 |
ispartof | Gastrointestinal endoscopy, 2016-10, Vol.84 (4), p.597-603 |
issn | 0016-5107 1097-6779 |
language | eng |
recordid | cdi_proquest_miscellaneous_1820598846 |
source | Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list) |
subjects | Acetonitriles - blood Acrylonitrile - blood Adenocarcinoma - blood Adenocarcinoma - diagnosis Adult Aged Area Under Curve Butadienes - blood Carbon Disulfide - blood Case-Control Studies Cross-Sectional Studies Endoscopy, Digestive System Esophageal Neoplasms - blood Esophageal Neoplasms - diagnosis Ethylamines - blood Female Gastroenterology and Hepatology Gastroesophageal Reflux - blood Gastroesophageal Reflux - diagnosis Hemiterpenes - blood Hexanes - blood Humans Hydrogen Sulfide - blood Logistic Models Male Middle Aged Multivariate Analysis Pentanes - blood Pilot Projects Volatile Organic Compounds - blood |
title | Volatile organic compounds in plasma for the diagnosis of esophageal adenocarcinoma: a pilot study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T22%3A23%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Volatile%20organic%20compounds%20in%20plasma%20for%20the%20diagnosis%20of%C2%A0esophageal%20adenocarcinoma:%20a%20pilot%20study&rft.jtitle=Gastrointestinal%20endoscopy&rft.au=Bhatt,%20Amit,%20MD&rft.date=2016-10-01&rft.volume=84&rft.issue=4&rft.spage=597&rft.epage=603&rft.pages=597-603&rft.issn=0016-5107&rft.eissn=1097-6779&rft_id=info:doi/10.1016/j.gie.2015.11.031&rft_dat=%3Cproquest_cross%3E1820598846%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c408t-d9fb07e4fe14765bc00d8d38271f6fb8e4101ba8f6fbb9e46a4084a56e7b2ba3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1820598846&rft_id=info:pmid/26646671&rfr_iscdi=true |